• Separating Growth Inhibition from Cell Death in Cancer

  2026-08-24

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly interchangeable measures capture different components of an in vitro cancer drug response. The framework encourages time-aware, mechanism-conscious interpretation so that cytostatic effects are not mistaken for cell killing.

• Phosbind Acrylamide for AMPK Phosphorylation

  2026-08-24

  Phosbind Acrylamide enables antibody-free visualization of phosphorylation-dependent mobility shifts in SDS-PAGE. This article connects the assay to the AMPKα2 nutrient-sensing mechanism and explains how to interpret, optimize, and validate phosphorylation results.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus

  2026-08-23

  Build translation-ready, ARCA-capped mRNA with a defined template-encoded poly(A) tail for vaccine, reporter, and functional RNA workflows. This guide connects practical synthesis and QC decisions with an HCC nanovaccine study while separating product specifications from assay-specific optimization.

• MTT Assays: From Signal to Scientific Decision

  2026-08-22

  MTT transforms cellular redox activity into a practical colorimetric readout for in vitro viability and proliferation studies. This guide goes beyond mechanism to show how to interpret MTT data when screening biomaterials, drug-delivery systems, and formulation safety.

• Dronedarone Workflows for Cardiac Research

  2026-08-22

  Build more reproducible atrial electrophysiology assays with Dronedarone (Multaq), from solvent handling and automated patch clamp to mechanism-focused controls. This guide distinguishes broad antiarrhythmic pharmacology from direct KCa2-channel effects so negative results become informative rather than inconclusive.

• Protease and Phosphatase Inhibitor Cocktail for HMGB1

  2026-08-21

  Learn how a Protease and Phosphatase Inhibitor Cocktail can preserve HMGB1 modification states during macrophage and sepsis research. This guide translates lactate-driven signaling biology into practical extraction, fractionation, and assay decisions.

• Somatic Mutations Broaden SARS-CoV-2 Antibody Neutralization

  2026-08-20

  Wu et al. show that the clonally related antibody XG005 acquired unusually broad and potent SARS-CoV-2 neutralization through fortuitous somatic mutations. Structural comparisons, variant neutralization studies, and mouse challenge experiments connect individual antibody residues with Omicron activity and therapeutic performance.

• Hypoxia and Immunometabolism in Tumors

  2026-08-20

  The 2025 Cancer Letters review integrates tumor hypoxia, metabolic reprogramming, nutrient competition, and immune dysfunction into a unified explanation of immunosuppressive tumor microenvironment formation. Its main practical value is a mechanistic framework for designing oxygen-, nutrient-, and immune-metabolism experiments while recognizing that proposed therapeutic strategies remain context-dependent.

• Rotigotine as a Translational Dopamine Probe

  2026-08-19

  Rotigotine is more than a symptomatic dopaminergic tool. Its receptor breadth, neuroprotective research signals, and route-dependent effects on bladder function position it as a valuable translational probe for linking motor, autonomic, and cellular phenotypes in Parkinson’s disease research.

• H. pylori, HNF4A, and Gastric Cancer Epigenetics

  2026-08-19

  This 2025 study identifies promoter hypermethylation-mediated silencing of HNF4A as a mechanistic link between Helicobacter pylori infection, epithelial polarity loss, EMT activation, and gastric cancer progression. Its integrated clinical, single-cell, methylation, perturbation, rescue, and in vivo analyses provide a framework for studying infection-driven epigenetic reprogramming.

• Drosophila Keap1–Lamin Control of Chromatin

  2026-08-18

  The reference study identifies a functional interaction between Drosophila Keap1 and the B-type lamin Dm0, linking xenobiotic and oxidative-response signaling to nuclear lamina organization and heterochromatin distribution. Its combined localization, chromatin-marker, and genetic evidence suggests that dKeap1 can influence development partly by remodeling higher-order nuclear architecture.

• Angiotensin I: A Decapeptide Assay Framework

  2026-08-18

  Angiotensin I is more than a precursor of angiotensin II: it is a controllable substrate for dissecting renin-angiotensin system research, cardiovascular disease mechanisms, and peptide-dependent assay behavior. This guide connects molecular identity, experimental design, and recent spike–receptor binding evidence to improve interpretation and reproducibility.

• FOXM1 and ceRNA Biomarkers in Female LUAD

  2026-08-17

  This study integrates public transcriptomic datasets, ceRNA-network analysis, immune-related computational profiling, and cellular validation to examine FOXM1 in female lung adenocarcinoma. Its central finding is a proposed DGCR5–miR-204-5p–FOXM1–estrogen receptor axis, although the incomplete validation of DGCR5 highlights the need for further mechanistic testing.

• Nebivolol hydrochloride: β1 Signaling Workflow

  2026-08-17

  Nebivolol hydrochloride enables a focused workflow for β1-adrenergic receptor signaling research, from concentration-response studies to pathway-level validation. Its negative result in a drug-sensitized yeast mTOR screen is equally useful, helping researchers distinguish cardiovascular receptor pharmacology from nonspecific TOR-pathway activity.

• p38α Dephosphorylation by Dual-Action Inhibitors

  2026-08-16

  A recent preprint shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Biochemical and X-ray structural data connect this effect to an inhibitor-stabilized activation-loop conformation, offering a framework for designing inhibitors that promote both immediate inhibition and durable pathway shutdown.

7706 records 1/514 page Next 12345 下5页 Last page